Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Bhag Karamchandani who wrote (5164)	8/24/1998 2:44:00 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 6136

[ off topic ] >> Any views on Generex Biotechnology << Bhag: No, don't follow them. I'll take a look at the web site, but I've been burned once by oral delivery of proteins and therefore don't have confidence in my ability to distinguish the good from bad. You'll want to look at Emisphere (EMIS) and their relationship with Lilly. They've got some decent data on oral heparin in a collaboration with Elan. I don't know if you're talking "fast" or "slow" insulin, but you should also look at Inhale/Pfizer (INHL) and Aradigm/Novo Nordisk (ARDM). The INHL thread here at SI might be a good place to ask about Generex...... anyone that contributes there might be concerned about them and they should also be watching EMIS?? Rick